entertainment -WSS

entertainment

author：entertainment 2025-09-27 10:04:28 - browse：16

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Gain of function research would be limited under House proposal

explore

WSS

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Anthos stroke drug appears safer than common blood thinner

FDA rejects Alnylam's heart disease treatment over insufficient data

Why age limits for politicians are a terrible idea

Stroke deaths set to near 10 million globally by 2050

Ransomware attacks on hospitals: Study outlines patient impact

knowledge

entertainment

explore

23andMe had bad news about my health. I wish a person had delivered it

When women are denied an abortion, their children fare worse than peers

23andMe had bad news about my health. I wish a person had delivered it

Gain of function research would be limited under House proposal

Moonlake's readout produced a cash windfall. Risks remain

Senate panel eyes new effort on drug shortages

Medicare details structure of new drug price negotiation program

Bill would stop addiction treatment from triggering child abuse inquiry

As demand for Covid shots wanes, Moderna seeks its next success

Morphosys mixed study results for blood cancer drug

entertainment

Why medical students are struggling with mental health

Childhood cancer progress stalls for Black, Hispanic kids: Report

Childhood cancer progress stalls for Black, Hispanic kids: Report

NYU radiologists take on the challenge of expensive MRI machines

Sana to lay off nearly a third of staff, de

Phenylephrine and the overlooked value of the placebo effect

knowledge

explore

focus

focus